Atara Biotherapeutics

$16.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+1.02%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ATRA and other stocks, options, and ETFs commission-free!

About ATRA

Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. The listed name for ATRA is Atara Biotherapeutics, Inc. Common Stock.

CEO
Pascal Touchon
Employees
393
Headquarters
South San Francisco, California
Founded
2012
Market Cap
1.41B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
667.07K
High Today
$17.15
Low Today
$16.29
Open Price
$16.72
Volume
572.92K
52 Week High
$28.20
52 Week Low
$4.52

ATRA Earnings

-$1.60
-$1.07
-$0.53
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.74 per share
Actual
Available Mar 1, After Hours

You May Also Like

CPRT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure